NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 309 filers reported holding NEOGENOMICS INC in Q4 2021. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,555,000 | -29.7% | 221,424 | -0.6% | 0.59% | -36.5% |
| Q3 2021 | $10,751,000 | +9.3% | 222,870 | +2.3% | 0.92% | +8.8% |
| Q2 2021 | $9,839,000 | -2.3% | 217,827 | +4.3% | 0.85% | -9.2% |
| Q1 2021 | $10,074,000 | -28.5% | 208,881 | -20.2% | 0.93% | -29.7% |
| Q4 2020 | $14,089,000 | +1.8% | 261,681 | -30.2% | 1.33% | -11.7% |
| Q3 2020 | $13,839,000 | -1.8% | 375,132 | -17.6% | 1.50% | -12.4% |
| Q2 2020 | $14,098,000 | +51.3% | 455,079 | +35.0% | 1.72% | +22.8% |
| Q1 2020 | $9,315,000 | -6.5% | 337,197 | -1.3% | 1.40% | +17.4% |
| Q4 2019 | $9,967,000 | +54.1% | 341,644 | +1.7% | 1.19% | +47.6% |
| Q3 2019 | $6,466,000 | -13.7% | 336,022 | -1.6% | 0.81% | -14.8% |
| Q2 2019 | $7,492,000 | +7.0% | 341,570 | -0.3% | 0.95% | +2.6% |
| Q1 2019 | $7,004,000 | +64.0% | 342,629 | +1.8% | 0.92% | +38.0% |
| Q4 2018 | $4,271,000 | -17.1% | 336,578 | +0.1% | 0.67% | -0.9% |
| Q3 2018 | $5,149,000 | – | 336,142 | – | 0.67% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,516,313 | $14,011 | 8.43% |
| Greenhouse Funds LLLP | 2,795,231 | $25,827,934 | 2.36% |
| First Light Asset Management, LLC | 2,682,171 | $24,783,260 | 2.30% |
| PERKINS CAPITAL MANAGEMENT INC | 197,700 | $1,827 | 1.93% |
| Altium Capital Management LP | 285,000 | $2,633,400 | 1.34% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,654,543 | $15,287,977 | 0.95% |
| EMERALD ADVISERS, LLC | 2,101,567 | $19,418,479 | 0.94% |
| Bullseye Asset Management LLC | 105,997 | $980 | 0.53% |
| OAK FAMILY ADVISORS, LLC | 101,194 | $935,033 | 0.50% |
| FORMULA GROWTH LTD | 180,300 | $1,665,972 | 0.47% |